Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-008245

President sold 30,000 shares at an average $59.37 ($1,781,100)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-03 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-02-03 Sale : show line 2 in the form −8,655 $59.39 $514,020 6,345 D
2021-02-03 Sale : show line 3 in the form −5,435 $60.16 $326,970 910 D
2021-02-03 Sale : show line 4 in the form −910 $60.82 $55,346 0 D
2021-02-04 Exercise or conversion : show line 5 in the form +15,000 $6.32 $94,800 15,000 D
2021-02-04 Sale : show line 6 in the form −8,305 $58.77 $488,085 6,695 D
2021-02-04 Sale : show line 7 in the form −6,695 $59.25 $396,679 0 D
Open-market sales · 30,000 sh · avg $59.37 · $1,781,100

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-03 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −15,000 50,000 D
2021-02-04 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −15,000 35,000 D
Loading xslF345X03/doc4.xml…